Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study
2016-01-01 Petrillo, M.; Amadio, G.; Salutari, V.; Paris, I.; Di Stefano, M. G.; Ferandina, G.; Scambia, G.; Fagotti, A.
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study
2020-01-01 Bogani, G.; DI DONATO, V.; Sopracordevole, F.; Ciavattini, A.; Ghelardi, A.; Lopez, S.; Simoncini, T.; Plotti, F.; Casarin, J.; Serati, M.; Pinelli, C.; Valenti, G.; Bergamini, A.; Gardella, B.; Dell'Acqua, A.; Monti, E.; Vercellini, P.; Fischetti, M.; D'Ippolito, G.; Aguzzoli, L.; Mandato, V. D.; Carunchio, P.; Carlinfante, G.; Giannella, L.; Scaffa, C.; Falcone, F.; Borghi, C.; Ditto, A.; Malzoni, M.; Giannini, A.; Salerno, M. G.; Liberale, V.; Contino, B.; Donfrancesco, C.; Desiato, M.; Perrone, A. M.; Dondi, G.; De IACO, P.; LEONE ROBERTI MAGGIORE, U.; Signorelli, M.; Chiappa, V.; Ferrero, S.; Sarpietro, G.; Matarazzo, M. G.; Cianci, A.; Bosio, S.; Ruisi, S.; Guerrisi, R.; Brusadelli, C.; Mosca, L.; Tinelli, R.; DE VINCENZO, R.; Zannoni, G. F.; Ferrandina, G.; Petrillo, M.; Dessole, S.; Angioli, R.; Greggi, S.; Spinillo, A.; Ghezzi, F.; Colacurci, N.; Muzii, L.; BENEDETTI PANICI, P.; Scambia, G.; Raspagliesi, F.
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: Long-term results
2013-01-01 Ferrandina, G.; Distefano, M. G.; De Vincenzo, R.; Salutari, V.; Petrillo, M.; Scarciglia, M. L.; Pietragalla, A.; Conte, C.; Scambia, G.
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: Utility of a scoring system to predict outcomes
2019-01-01 Nero, C.; Fagotti, A.; Zannoni, G. F.; Palluzzi, E.; Scambia, G.; Petrillo, M.
Secondary cytoreduction in ovarian cancer: who really benefits?
2018-01-01 Giudice, M. T.; D'Indinosante, M.; Cappuccio, S.; Gallotta, V.; Fagotti, A.; Scambia, G.; Petrillo, M.
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: A multicenter, retrospective, observational pilot study in Italy
2011-01-01 Mennini, F. S.; Panatto, D.; Marcellusi, A.; Cristoforoni, P.; De Vincenzo, R.; Di Capua, E.; Ferrandina, G.; Petrillo, M.; Sasso, T.; Ricci, C.; Trivellizzi, N.; Capone, A.; Scambia, G.; Gasparini, R.
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case-Matched Control Study
2017-01-01 Gallotta, V.; Cicero, C.; Conte, C.; Vizzielli, G.; Petrillo, M.; Fagotti, A.; Chiantera, V.; Costantini, B.; Scambia, G.; Ferrandina, G.
Epithelial ovarian cancer relapsing as isolated lymph node disease: Natural history and clinical outcome
2008-01-01 Legge, F.; Petrillo, M.; Adamo, V.; Pisconti, S.; Scambia, G.; Ferrandina, G.
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge
2007-01-01 Ferrandina, G.; Legge, F.; Mey, V.; Nannizzi, S.; Ricciardi, S.; Petrillo, M.; Corrado, G.; Scambia, G.
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience
2014-01-01 Vizzielli, G.; Costantini, B.; Tortorella, L.; Petrillo, M.; Fanfani, F.; Chiantera, V.; Ercoli, A.; Iodice, R.; Scambia, G.; Fagotti, A.
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis
2014-01-01 Petrillo, M.; Pedone Anchora, L.; Tortorella, L.; Fanfani, F.; Gallotta, V.; Pacciani, M.; Scambia, G.; Fagotti, A.
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer
2017-01-01 Leonardi, S.; Buttarelli, M.; De Stefano, I.; Ferrandina, G.; Petrillo, M.; Babini, G.; Scambia, G.; Marino, C.; Mancuso, M.; Gallo, D.
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer
2019-01-01 Buttarelli, M.; Babini, G.; Raspaglio, G.; Filippetti, F.; Battaglia, A.; Ciucci, A.; Ferrandina, G.; Petrillo, M.; Marino, C.; Mancuso, M.; Saran, A.; Villani, M. E.; Desiderio, A.; D'Ambrosio, C.; Scaloni, A.; Scambia, G.; Gallo, D.
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery
2010-01-01 Ferrandina, G.; Margariti, P. A.; Smaniotto, D.; Petrillo, M.; Salerno, M. G.; Fagotti, A.; Macchia, G.; Morganti, A. G.; Cellini, N.; Scambia, G.
Feasibility and safety of laparoscopic approach in obese patients with endometriosis: a multivariable regression analysis
2020-01-01 Raimondo, D.; Raimondo, I.; Degli Esposti, E.; Mattioli, G.; Mastronardi, M.; Petrillo, M.; Dessole, S.; Mabrouk, M.; Del Forno, S.; Arena, A.; Borghese, G.; Seracchioli, R.
Incidence and predictive factors for complications after uterine leiomyoma embolization
2014-01-01 Tropeano, G.; Amoroso, S.; Di Stasi, C.; Di Bidino, R.; Monterisi, A.; Petrillo, M.; Scambia, G.
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases
2016-01-01 Zannoni, G. F.; Improta, G.; Petrillo, M.; Pettinato, A.; Scambia, G.; Fraggetta, F.
Minimally Invasive Secondary Cytoreduction Plus HIPEC Versus Open Surgery Plus HIPEC in Isolated Relapse From Ovarian Cancer: A Retrospective Cohort Study on Perioperative Outcomes
2015-01-01 Fagotti, A.; Costantini, B.; Gallotta, V.; Cianci, S.; Ronsini, C.; Petrillo, M.; Pacciani, M.; Scambia, G.; Fanfani, F.
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
2016-01-01 Petrillo, M.; De Iaco, P.; Cianci, S.; Perrone, M.; Costantini, B.; Ronsini, C.; Scambia, G.; Fagotti, A.
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study
2014-01-01 Ferrandina, G.; Petrillo, M.; Mantegna, G.; Fuoco, G.; Terzano, S.; Venditti, L.; Marcellusi, A.; De Vincenzo, R.; Scambia, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study | 1-gen-2016 | Petrillo, M.; Amadio, G.; Salutari, V.; Paris, I.; Di Stefano, M. G.; Ferandina, G.; Scambia, G.; Fagotti, A. | |
| Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study | 1-gen-2020 | Bogani, G.; DI DONATO, V.; Sopracordevole, F.; Ciavattini, A.; Ghelardi, A.; Lopez, S.; Simoncini, T.; Plotti, F.; Casarin, J.; Serati, M.; Pinelli, C.; Valenti, G.; Bergamini, A.; Gardella, B.; Dell'Acqua, A.; Monti, E.; Vercellini, P.; Fischetti, M.; D'Ippolito, G.; Aguzzoli, L.; Mandato, V. D.; Carunchio, P.; Carlinfante, G.; Giannella, L.; Scaffa, C.; Falcone, F.; Borghi, C.; Ditto, A.; Malzoni, M.; Giannini, A.; Salerno, M. G.; Liberale, V.; Contino, B.; Donfrancesco, C.; Desiato, M.; Perrone, A. M.; Dondi, G.; De IACO, P.; LEONE ROBERTI MAGGIORE, U.; Signorelli, M.; Chiappa, V.; Ferrero, S.; Sarpietro, G.; Matarazzo, M. G.; Cianci, A.; Bosio, S.; Ruisi, S.; Guerrisi, R.; Brusadelli, C.; Mosca, L.; Tinelli, R.; DE VINCENZO, R.; Zannoni, G. F.; Ferrandina, G.; Petrillo, M.; Dessole, S.; Angioli, R.; Greggi, S.; Spinillo, A.; Ghezzi, F.; Colacurci, N.; Muzii, L.; BENEDETTI PANICI, P.; Scambia, G.; Raspagliesi, F. | |
| Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: Long-term results | 1-gen-2013 | Ferrandina, G.; Distefano, M. G.; De Vincenzo, R.; Salutari, V.; Petrillo, M.; Scarciglia, M. L.; Pietragalla, A.; Conte, C.; Scambia, G. | |
| Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: Utility of a scoring system to predict outcomes | 1-gen-2019 | Nero, C.; Fagotti, A.; Zannoni, G. F.; Palluzzi, E.; Scambia, G.; Petrillo, M. | |
| Secondary cytoreduction in ovarian cancer: who really benefits? | 1-gen-2018 | Giudice, M. T.; D'Indinosante, M.; Cappuccio, S.; Gallotta, V.; Fagotti, A.; Scambia, G.; Petrillo, M. | |
| Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: A multicenter, retrospective, observational pilot study in Italy | 1-gen-2011 | Mennini, F. S.; Panatto, D.; Marcellusi, A.; Cristoforoni, P.; De Vincenzo, R.; Di Capua, E.; Ferrandina, G.; Petrillo, M.; Sasso, T.; Ricci, C.; Trivellizzi, N.; Capone, A.; Scambia, G.; Gasparini, R. | |
| Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case-Matched Control Study | 1-gen-2017 | Gallotta, V.; Cicero, C.; Conte, C.; Vizzielli, G.; Petrillo, M.; Fagotti, A.; Chiantera, V.; Costantini, B.; Scambia, G.; Ferrandina, G. | |
| Epithelial ovarian cancer relapsing as isolated lymph node disease: Natural history and clinical outcome | 1-gen-2008 | Legge, F.; Petrillo, M.; Adamo, V.; Pisconti, S.; Scambia, G.; Ferrandina, G. | |
| A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge | 1-gen-2007 | Ferrandina, G.; Legge, F.; Mey, V.; Nannizzi, S.; Ricciardi, S.; Petrillo, M.; Corrado, G.; Scambia, G. | |
| Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience | 1-gen-2014 | Vizzielli, G.; Costantini, B.; Tortorella, L.; Petrillo, M.; Fanfani, F.; Chiantera, V.; Ercoli, A.; Iodice, R.; Scambia, G.; Fagotti, A. | |
| Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis | 1-gen-2014 | Petrillo, M.; Pedone Anchora, L.; Tortorella, L.; Fanfani, F.; Gallotta, V.; Pacciani, M.; Scambia, G.; Fagotti, A. | |
| The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer | 1-gen-2017 | Leonardi, S.; Buttarelli, M.; De Stefano, I.; Ferrandina, G.; Petrillo, M.; Babini, G.; Scambia, G.; Marino, C.; Mancuso, M.; Gallo, D. | |
| A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer | 1-gen-2019 | Buttarelli, M.; Babini, G.; Raspaglio, G.; Filippetti, F.; Battaglia, A.; Ciucci, A.; Ferrandina, G.; Petrillo, M.; Marino, C.; Mancuso, M.; Saran, A.; Villani, M. E.; Desiderio, A.; D'Ambrosio, C.; Scaloni, A.; Scambia, G.; Gallo, D. | |
| Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery | 1-gen-2010 | Ferrandina, G.; Margariti, P. A.; Smaniotto, D.; Petrillo, M.; Salerno, M. G.; Fagotti, A.; Macchia, G.; Morganti, A. G.; Cellini, N.; Scambia, G. | |
| Feasibility and safety of laparoscopic approach in obese patients with endometriosis: a multivariable regression analysis | 1-gen-2020 | Raimondo, D.; Raimondo, I.; Degli Esposti, E.; Mattioli, G.; Mastronardi, M.; Petrillo, M.; Dessole, S.; Mabrouk, M.; Del Forno, S.; Arena, A.; Borghese, G.; Seracchioli, R. | |
| Incidence and predictive factors for complications after uterine leiomyoma embolization | 1-gen-2014 | Tropeano, G.; Amoroso, S.; Di Stasi, C.; Di Bidino, R.; Monterisi, A.; Petrillo, M.; Scambia, G. | |
| FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases | 1-gen-2016 | Zannoni, G. F.; Improta, G.; Petrillo, M.; Pettinato, A.; Scambia, G.; Fraggetta, F. | |
| Minimally Invasive Secondary Cytoreduction Plus HIPEC Versus Open Surgery Plus HIPEC in Isolated Relapse From Ovarian Cancer: A Retrospective Cohort Study on Perioperative Outcomes | 1-gen-2015 | Fagotti, A.; Costantini, B.; Gallotta, V.; Cianci, S.; Ronsini, C.; Petrillo, M.; Pacciani, M.; Scambia, G.; Fanfani, F. | |
| Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | 1-gen-2016 | Petrillo, M.; De Iaco, P.; Cianci, S.; Perrone, M.; Costantini, B.; Ronsini, C.; Scambia, G.; Fagotti, A. | |
| Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study | 1-gen-2014 | Ferrandina, G.; Petrillo, M.; Mantegna, G.; Fuoco, G.; Terzano, S.; Venditti, L.; Marcellusi, A.; De Vincenzo, R.; Scambia, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista37989
- 4 Contributo in Atti di Convegno ...1
Data di pubblicazione
- In corso di stampa62
- 2020 - 20279364
- 2010 - 201912734
- 2000 - 20098933
- 1990 - 19994656
- 1980 - 19891792
- 1970 - 1979438
- 1965 - 196911
Editore
- Diritto @ storia220
- Gallizzi162
- Università degli studi di Sassari...160
- Public Library of Science135
- BioMed Central105
- Avenue media on behalf of Scienti...98
- Università degli studi di Sassari...79
- Università degli studi di Sassari...61
- Edagricole46
- Università degli studi di Sassari...45
Rivista
- DIRITTO@STORIA400
- PHYSICAL REVIEW D, PARTICLES, FIE...292
- PHYSICAL REVIEW LETTERS290
- STUDI SASSARESI. SEZIONE 3: ANNAL...283
- PLOS ONE281
- BOLLETTINO DELLA SOCIETÀ SARDA DI...178
- ANIMALS159
- BIOLOGIA MARINA MEDITERRANEA156
- JOURNAL OF CLINICAL MEDICINE153
- SANDALION153
Serie
- WORKING PAPERS OLYMPUS1
Keyword
- Humans701
- Sardinia643
- Sardegna420
- Female354
- Italy339
- Male320
- COVID-19288
- Middle Aged219
- Adult180
- SARS-CoV-2170
Lingua
- eng23782
- ita9603
- fre248
- spa172
- ger80
- lat31
- und28
- rus23
- por16
- cat15
Accesso al fulltext
- no fulltext33874
- open3619
- reserved293
- restricted136
- partially open66
- mixed2